Sep 14, 2026, 23:06 UTC
MindWalk Holdings Corp. reported a Q1 loss of $0.09 per share, missing the Zacks Consensus Estimate of a $0.05 loss and wider than the $0.07 loss a year earlier, with revenue also below estimates.
Source:Sep 14, 2026, 20:56 UTC
MindWalk Holdings Corp. reported fiscal 2027 first-quarter results for the quarter ended July 31, 2026, with revenue up 21.3% year over year to $3.8 million and gross margin expanding to 58.6% from 48.3%.
Source:Sep 14, 2026, 12:46 UTC
MindWalk Holdings Corp. entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million to fund biologics programs, commercial expansion, working capital, and general corporate purposes.
Source:Sep 8, 2026, 12:30 UTC
MindWalk Holdings Corp. announced it will report financial results for the first quarter of fiscal year 2027 and host a conference call on September 14, 2026.
Source:Jul 22, 2026, 20:54 UTC
MindWalk Holdings Corp. reported its fiscal 2026 financial results, with revenue up 46% year over year and net loss narrowing by more than half.
Jun 10, 2026, 13:16 UTC
MindWalk Holdings Corp. launched ReefIQ, a biological context layer for AI drug discovery and biologics development.
Source: